These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14497875)

  • 21. Chromatographic studies of purine metabolism. V. Inhibition mechanism of diazo-oxo-norleucine in wild-type and in diazo-oxo-norleucine-resistant Escherichia coli.
    TOMISEK AJ; REID MR
    J Biol Chem; 1962 Mar; 237():807-11. PubMed ID: 13921756
    [No Abstract]   [Full Text] [Related]  

  • 22. Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites.
    ELION GB; SINGER S; HITCHINGS GH
    J Biol Chem; 1954 Jun; 208(2):477-88. PubMed ID: 13174557
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolic conditioning and metabolic actuation: experimental approaches to cancer chemotherapy involving combinations of metabolites and antimetabolites.
    Bloch A
    Cancer Chemother Rep; 1974; 58(4):471-7. PubMed ID: 4853172
    [No Abstract]   [Full Text] [Related]  

  • 24. Experimental evaluation of potential anticancer agents. I. Quantitative therapeutic evaluation of certain purine analogs.
    SCHABEL FM; MONTGOMERY JA; SKIPPER HE; LASTER WR; THOMSON JR
    Cancer Res; 1961 Jun; 21():690-9. PubMed ID: 13747126
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical pharmacology of anticancer agents [Part 5] Antimetabolites (2)].
    Nakamura T; Ueda T; Uchida M
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):409-20. PubMed ID: 1543370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [PROBLEMS IN ACQUIRED RESISTANCE OF TUMORS TOWARDS CYTOSTATICS].
    UJHAZY V
    Bratisl Lek Listy; 1964; 44():562-8. PubMed ID: 14160201
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemotherapy of solid tumors.
    Alberto P
    Aktuelle Probl Chir; 1970; 14():807-34. PubMed ID: 4147168
    [No Abstract]   [Full Text] [Related]  

  • 28. [Influencing the immune status of cancer patients through chemotherapy].
    Micksche M
    Wien Med Wochenschr; 1975 Dec; 125(50-52):729-35. PubMed ID: 779283
    [No Abstract]   [Full Text] [Related]  

  • 29. Potential anticancer agents--L. Non-classical antimetabolites. II. Some factors in the design of exoalkylating enzyme inhibitors, particulary of lactic dehydrogenase.
    BAKER BR; LEE WW; SKINNER WA; MARTINEZ AP; TONG E
    J Med Pharm Chem; 1960 Dec; 2():633-57. PubMed ID: 14448433
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunosuppresive therapy of progredient chronic polyarthritis using antimetabolites and cytostatics].
    Gross D; Enderlin M; Fehr K
    Schweiz Med Wochenschr; 1967 Oct; 97(40):1301-10. PubMed ID: 4968560
    [No Abstract]   [Full Text] [Related]  

  • 31. SUMMARY OF INFORMAL DISCUSSION ON THE ROLE OF PURINE ANTAGONISTS.
    HITCHINGS GH
    Cancer Res; 1963 Sep; 23():1218-25. PubMed ID: 14070378
    [No Abstract]   [Full Text] [Related]  

  • 32. Purine antagonists and growth of Tetrahymena.
    DEWEY VC; KIDDER GW; MARKEES DG
    Proc Soc Exp Biol Med; 1959 Nov; 102():306-8. PubMed ID: 13816320
    [No Abstract]   [Full Text] [Related]  

  • 33. The present approach to systematic cancer therapy.
    Mukerjea DN; Koven BJ
    Indian J Cancer; 1970 Sep; 7(3):174-90. PubMed ID: 4927710
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunosuppression and chemotherapeutic agents.
    Kim Z
    Ann Allergy; 1981 Aug; 47(2):79-83. PubMed ID: 7258742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The need for additional alkylating agents and antimetabolites.
    Heidelberger C
    Cancer Res; 1969 Dec; 29(12):2435-42. PubMed ID: 4905240
    [No Abstract]   [Full Text] [Related]  

  • 36. Purinethiols as feedback inhibitors of purine synthesis in ascites tumor cells.
    LEPAGE GA; JONES M
    Cancer Res; 1961 Jun; 21():642-9. PubMed ID: 13760994
    [No Abstract]   [Full Text] [Related]  

  • 37. Special microbiological systems. III. The use of lactic acid bacteria for the evaluation of purine and pyrimidine antagonists.
    HITCHINGS GH
    Ann N Y Acad Sci; 1958 Dec; 76(3):490-5. PubMed ID: 13627874
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibitors of de novo purine and pyrimidine synthesis as immunosuppressive drugs.
    Allison AC; Eugui EM
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):8-18. PubMed ID: 8516951
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibitors of purine metabolism in Ehrlich ascites tumor cells in vitro.
    Lau KF; Henderson JF
    Cancer Chemother Rep 2; 1972 Nov; 3(1):95-109. PubMed ID: 4499907
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of 8-azaguanine and 6-mercaptopurine on purine catabolism in the rat.
    FEIGELSON P; ULTMANN JE
    Acta Unio Int Contra Cancrum; 1960; 16():609-10. PubMed ID: 13821915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.